Antiphospholipid antibodies and the risk of thrombosis: A comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome;Profil des anticorps antiphospholipides et risque de thrombose: Étude comparative entre thrombopénie immunologique chronique et syndrome des antiphospholipides primaire

Revue de Medecine Interne

Volumn 32, Issue 12, 2011, Pages 724-729

  Moulis, G ^a   Delavigne, K ^a   Huguet, F ^a   Fortenfant, F ^a   Beyne Rauzy, O ^a   Adoue, D ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Immune thrombocytopenic purpura

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VEIN THROMBOSIS;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; THROMBOSIS;

EID: 82255175012     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2011.07.014     Document Type: Article

References (30)

1. Uthman I., Godeau B., Taher A., Khamashta M. The hematologic manifestations of the antiphophoslipid syndrome. Blood Rev 2008, 22:187-194.
2. Cervera R., Piette J.C., Font J., Khamashta M.A., Shoenfeld Y., Camps M.T., et al. Antiphospholipid syndrome. Arthritis Rheum 2002, 46:1019-1027.
3. Meyer O., Piette J.C. Syndrome des antiphospholipides (syndrome de Hugues). Médecine-Sciences 2008, 300-345. Flammarion, Paris. L. Guillevin, O. Meyer, J. Sibilia (Eds.).
4. Neunert C., Lim W., Crowther M., Cohen A., Solberg L., Crowther M.A. The American society of hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011, 117:4190-4207.
5. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999, 42:1309-1311.
6. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
7. Harris E.N., Asherson R.A., Gharavi, Morgan S.H., Derue G., Hugues G.R.V. Thrombocytopenia in SLE and related disorders: association with anticardiolipin antibody. Br J Haematol 1985, 59:227-230.
8. Stasi R., Stipa E., Masi M., Oliva F., Sciarra A., Peroti A., et al. Prevalence and clinical relevance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 1994, 84:4203-4208.
9. årfors L., Winiarski J., Lefvert A.K. Prevalence of antibodies to cardiolipin in chronic ITP and reactivity with platelet membranes. Eur J Haematol 1996, 56:230-234.
10. Lipp E., von Felten A., Sax H., Müller D., Berchtold P. Antibodies against platelet glycoproteins and antiphospholipid antibodies in autoimmune thrombocytopenia. Eur J Haematol 1998, 60:283-288.
11. Diz-Küçükkaya R., Hacihanefioglu A., Yenerel M., Turgut M., Keskin H., Nalçaci M., et al. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood 2001, 98:1760-1764.
12. Bidot C.J., Jy W., Horstman L.L., Ahn E.R., Jimenez J.J., Yaniz M., et al. Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission. Br J Haematol 2004, 128:366-372.
13. Bidot C.J., Jy W., Horstman L.L., Ahn E.R., Yaniz M., Ahn Y.S. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS). Br J Haematol 2006, 81:391-396.
14. Pierrot-Desseilligny Despujol C., Michel M., Khellaf M., Gouault M., Intrator L., Bierling P., et al. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. Br J Haematol 2008, 142:638-643.
15. Stasi R., Stipa E., Masi M., Cecconi M., Scimo M.T., Oliva F., et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 1995, 88:436-442.
16. BCSH Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003, 120:574-596.
17. Comellas-Kirkerup L., Hernández-Molina G., Cabral A.R. Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a six-year follow-up study. Blood 2010, 116:3058-3063.
18. Italian registry of antiphospholipid antibodies (IR-APA) Thrombosis and thrombocytopenia in antiphospholipid syndrome (idiopathic or secondary to SLE): first report from the Italian registry. Haematologica 1993, 78:313-318.
19. Cuadrado M.J., Mujic F., Muñoz F., Khamashta M.A., Hugues G.R.V. Thrombocytopenia in the antiphospholipid syndrome. Ann Rheum Dis 1997, 56:194-196.
20. Cervera R., Piette J.C., Font J., Khamashta M.A., Shoenfeld Y., Camps M.T., et al. Antiphospholipid syndrome. Clinical and immunological manifestations and patterns of disease expression in a cohort or 1,000 patients. Arthritis Rheum 2002, 46:1019-1027.
21. Atsumi T., Furukawa S., Amengual O., Koike T. Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis. Lupus 2005, 14:499-504.
22. Krause I., Blank M., Fraser A., Lorber M., Stojanovitch L., Rivensky J., et al. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome. Immunobiology 2005, 210:749-754.
23. Galli M., Finazzi G., Barbui T. Thrombocytopenia in the antiphospholipid syndrome: pathophysiology, clinical relevance and treatment. Ann Med Interne 1996, 147(Suppl. 1):24-27.
24. Fabris F., Steffan A., Cordiano I., Borzini P., Luzzatto G., Randi M.L., et al. Specific antiplatelet antibodies in patients with antiphospholipid antibodies thrombocytopenia. J Haematol 1994, 53:232-236.
25. Godeau B., Piette J.C., Fromont P., Intrator L., Schaeffer A., Bierling P. Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome. Br J Haematol 1997, 98:873-879.
26. Kravitz M.S., Shoenfeld Y. Thrombocytopenic conditions-autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT, and APS. Am J Hematol 2005, 80:232-242.
27. Dunoyer-Geindre S., Boehlen F., Favier R., Wahl D., Musial J., Korte W., et al. Endothelial cell activation by immunoglobulins from patients with immune thrombocytopenic purpura or with antipospholipid syndrome. Haematologica 2008, 93:635-636.
28. Horstman L.L., Jy W., Bidot C.J., Ahn Y.S., Kelley R.E., Zidanov R., et al. Antiphospholipid antibodies: paradigm in transition. J Neuroinfl 2009, 6:3.
29. Fogarty P.F., Segal J.B. The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol 2007, 14:515-519.
30. Szymezak J., Ankri A., Fischer A.M., Darnige L. Hydroxychloroquine: une nouvelle approche thérapeutique des manifestations thrombotiques du syndrome des antiphospholipides. Rev Med Interne 2010, 31:854-857.